Aliases & Classifications for Pyoderma

About this section

Aliases & Descriptions for Pyoderma:

Name: Pyoderma 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:4223
ICD1027 L08.0
ICD9CM29 686.0, 686.00
MeSH36 D011711
UMLS65 C0034212

Summaries for Pyoderma

About this section
Wikipedia:68 Pyoderma means any skin disease that is pyogenic (has pus). These include superficial bacterial... more...

MalaCards based summary: Pyoderma is related to pyogenic granuloma and calcific tendinitis. An important gene associated with Pyoderma is PSTPIP1 (Proline-Serine-Threonine Phosphatase Interacting Protein 1), and among its related pathways are 14-3-3 and Regulation of BAD Activity and Osteoclast differentiation. Affiliated tissues include skin, bone and lung, and related mouse phenotypes are integument and tumorigenesis.

Disease Ontology:10 Pyoderma is a skin infectious disease where the infection is pyogenic causing the formation of pus.

Related Diseases for Pyoderma

About this section

Diseases related to Pyoderma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 582)
idRelated DiseaseScoreTop Affiliating Genes
1pyogenic granuloma30.3IL1R1, PSTPIP1
2calcific tendinitis29.9BTK, CD79A
3generalized anxiety disorder29.9CD79A, IL1R1
4rheumatoid arthritis29.4CD79A, IL1R1, TNF, TNFRSF1B
5leishmaniasis29.1CD79A, DSG1, EDNRB
6pyoderma gangrenosum12.7
7pyogenic sterile arthritis, pyoderma gangrenosum, and acne12.4
8pyogenic arthritis, pyoderma gangrenosum and acne12.4
9pyoderma gangrenosum-acne-suppurative hidradenitis syndrome12.3
10polydactyly, postaxial, types a1 and b11.3
11crohn's disease10.7
12waardenburg syndrome type 410.4IL1R1, TNF
13occipital lobe neoplasm10.4PSTPIP1, TNF
14t cell immunodeficiency primary10.4IL1R1, TNF
15turner syndrome10.4IL1R1, TNF
16ureteral disease10.4IL1R1, TNF
17skin conditions10.3BTK, TNF
18pustulosis of palm and sole10.3TNF, TNFRSF1B
19cerebral sarcoidosis10.3TNF, TNFRSF1B
20brain stem glioma10.3TNF, TNFRSF1B
21central nervous system melanocytic neoplasm10.3BTK, TNF
22exocrine pancreatic insufficiency10.3C7, MMP10
23telangiectasis10.3TNF, TNFRSF1B
24leukemia10.3
25gonococcal bursitis10.3TNF, TNFRSF1B
26ileocolitis10.3
27cutaneous diphtheria10.3
28impetigo10.3
29exophthalmos10.3IFNA2, TNFRSF1B
30patent ductus arteriosus10.3PSTPIP1, TNFRSF1B
31benign secondary hypertension10.3IFNA2, IL1R1, TNF
32brucella melitensis brucellosis10.3CD79A, TNF
33chromosome 9p deletion syndrome10.2TNF, TNFRSF1B
34opisthorchiasis10.2CD79A, TNF
35spinocerebellar ataxia, autosomal recessive 1010.2CD79A, IFNA2
36pelvic inflammatory disease10.2CD79A, IFNA2
37collagenous colitis10.2CD79A, TNF
38arthritis10.2
39thyroiditis10.2
40endotheliitis10.2
41lens subluxation10.2CD79A, IFNA2
42refractory plasma cell neoplasm10.2CD79A, TNF
43transient cerebral ischemia10.2CD79A, IFNA2
44shigellosis10.2CD79A, IFNA2
45argentine hemorrhagic fever10.2CD79A, TNF
46prostatitis10.2
47pancreatitis10.2
48familial mediterranean fever, ad10.2PSTPIP1, TNF
49b cell deficiency10.2CD79A, TNF
50diffuse intraductal papillomatosis10.2CD79A, TNF

Graphical network of the top 20 diseases related to Pyoderma:



Diseases related to pyoderma

Symptoms for Pyoderma

About this section

Drugs & Therapeutics for Pyoderma

About this section

Drugs for Pyoderma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Anti-Infective AgentsPhase 4, Phase 317220
2Anti-Bacterial AgentsPhase 4, Phase 39140
3
Minocyclineapproved, investigationalPhase 317310118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
HMS2090D03
HSDB 3130
LMPK07000002
 
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline
Minocycline (USAN/INN)
Minocycline Hydrochloride
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
NCGC00178854-01
NSC 141993
NSC141993
Solodyn
UNII-FYY3R43WGO
Vectrin (Hydrochloride)
Ximino
minociclinum
minocycline
nchembio.559-comp1
4Pharmaceutical SolutionsPhase 3, Phase 27004
5
Tacrolimusapproved, investigationalPhase 21023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
6Antirheumatic AgentsPhase 28496
7Calcineurin InhibitorsPhase 21223
8Immunosuppressive AgentsPhase 210422
9Immunologic FactorsPhase 218483
10ImmunoglobulinsPhase 24477
11Antibodies, MonoclonalPhase 22413
12AntibodiesPhase 24477
13
Amoxicillinapproved39126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
14
Infliximabapproved349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
15Beta-Lactamase Inhibitors245
16Clavulanic Acids147
17Amoxicillin-Potassium Clavulanate Combination121
18Vaccines6085
19Dermatologic Agents4555
20Gastrointestinal Agents6401

Interventional clinical trials:

(show all 21)
idNameStatusNCT IDPhase
1Sisomicin Cream Vs Nadifloxacin Cream in Primary Pyodermas (Study P04460)WithdrawnNCT00202891Phase 4
2Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot StudyActive, not recruitingNCT00203697Phase 3
3An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02326740Phase 3
4An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02315417Phase 3
5A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma GangrenosumTerminatedNCT02318914Phase 3
6Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma GangrenosumCompletedNCT01882504Phase 2
7Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
8RA-18C3 Therapy for Subjects With Pyoderma GangrenosumRecruitingNCT01965613Phase 2
9Canakinumab for Pyoderma GangrenosumRecruitingNCT01302795Phase 2
10Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma GangrenosumNot yet recruitingNCT02733094Phase 1, Phase 2
11Safety and Efficacy Study of Humira in Treatment of Pyoderma GangrenosumWithdrawnNCT00730717Phase 2
12Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma GangrenosumWithdrawnNCT00690846Phase 2
13Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseCompletedNCT00791557
14Prevalence of RHD, Pyoderma and Scabies in Children in FijiCompletedNCT00284843
15Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in FijiCompletedNCT00436891
16Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern TerritoryCompletedNCT00884728
17Incidence of Group A Strep Pharyngitis in School Children in FijiCompletedNCT00284882
18Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)CompletedNCT01406275
19Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesRecruitingNCT01952275
20A Real World, Observational Registry of Chronic Wounds and UlcersRecruitingNCT02280733
21Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic FactorsRecruitingNCT00933296

Search NIH Clinical Center for Pyoderma


Cochrane evidence based reviews: pyoderma

Genetic Tests for Pyoderma

About this section

Anatomical Context for Pyoderma

About this section

MalaCards organs/tissues related to Pyoderma:

33
Skin, Bone, Lung, T cells, Breast, Neutrophil, Prostate

Animal Models for Pyoderma or affiliated genes

About this section

MGI Mouse Phenotypes related to Pyoderma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.1BTK, EDNRB, IL1R1, IL36RN, TNF, TNFRSF1B
2MP:00020068.0BTK, CD79A, EDNRB, IL1R1, TNF, TNFRSF1B
3MP:00053876.5BTK, CD79A, EDNRB, IL1R1, IL36RN, MMP10

Publications for Pyoderma

About this section

Articles related to Pyoderma:

(show top 50)    (show all 756)
idTitleAuthorsYear
1
Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity. (26387946)
2015
2
Passive immunity in the prevention of rabies. (22541629)
2012
3
Surgical approach in a patient with multiple symmetrical lipomatosis: case report. (22392254)
2012
4
KAP1 protein: an enigmatic master regulator of the genome. (21652716)
2011
5
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri. (21710625)
2011
6
Treatment of acute anterior cruciate ligament tears. (21668053)
2011
7
Recent discovery of widespread Ixodes affinis (Acari: Ixodidae) distribution in North Carolina with implications for Lyme disease studies. (20618664)
2010
8
The longitudinal profile of CSF markers during external lumbar drainage. (19535354)
2009
9
A highly reproducible rotenone model of Parkinson's disease. (19385059)
2009
10
Serum adiponectin, leptin level, and bone mineral density in postmenopausal women]. (19587442)
2009
11
Lopinavir co-induces insulin resistance and ER stress in human adipocytes. (19501568)
2009
12
Comparative assessment of antiinflammatory action of atorvastatin in ischemic heart disease and rheumatoid arthritis]. (18991814)
2008
13
Umbilical venous volume flow in twin-twin transfusion syndrome. (18837441)
2008
14
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. (18362486)
2008
15
Synergistic effect of thermotherapy in combination with chemotherapy on lung tumor A549 cells growth through activation of c-Jun N-terminal kinase and inhibition of heat shock protein70 expression]. (19069644)
2008
16
A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study. (17488248)
2007
17
Hypermethylation of the Dal-1 gene in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats. (17415786)
2007
18
G1-G2 aggrecan product that can be generated by M-calpain on truncation at Ala709-Ala710 is present abundantly in human articular cartilage. (17261541)
2007
19
Therapeutic efficacy of sulfadoxin/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Enseno, Meskan Woreda, Gurage zone, SNNPR, Ethiopia. (17447375)
2006
20
No evidence of an association between tyrosine hydroxylase gene polymorphisms and suicide victims. (17329957)
2006
21
A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease. (15912389)
2005
22
Differences in dental and bone maturation in regions with or without hemihypertrophy in two patients with Russell-Silver syndrome. (16128247)
2005
23
Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. (14726464)
2004
24
Inverted terminal repeat sequences of adeno-associated virus enhance the antibody and CD8(+) responses to a HIV-1 p55Gag/LAMP DNA vaccine chimera. (15193918)
2004
25
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. (15561602)
2004
26
Echinococcus granulosus cattle strain identification in an autochthonous case of cystic echinococcosis in central Mexico. (15533292)
2004
27
Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes. (12832416)
2003
28
Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. (12913924)
2003
29
Rehabilitating a patient with bruxism-associated tooth tissue loss: a literature review and case report. (15061339)
2003
30
Synergistic antitumour effect of a combination of toremifene and interferon-alpha on ZR-75-1 human breast cancer cells: dependence on interferon-alpha subtype. (11836612)
2002
31
Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis. (12460647)
2002
32
Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. (11740803)
2001
33
Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. (11133502)
2001
34
A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding. (10595557)
1999
35
The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: possible involvement of Src homology 2 domains. (10458595)
1999
36
The Strange Stories Test: a replication with high-functioning adults with autism or Asperger syndrome. (10587886)
1999
37
On-line flow displacement immunoassay for fatty acid-binding protein. (9776580)
1998
38
Advanced testicular germ cell tumor in a hemophilic patient with human immunodeficiency virus infection. (9793032)
1998
39
Total hip reconstruction in a woman with Cornelia de Lange syndrome: a case report. (9264220)
1997
40
Analysis of the endoplasmic reticular Ca2+ requirement for alpha1-antitrypsin processing and transport competence. (9271078)
1997
41
Differential regulation of leukocyte function-associated antigen-1/ intercellular adhesion molecules-1-dependent adhesion and aggregation in HL-60 cells. (8639786)
1996
42
Different target specificities of phospholipid-dependent antibodies. (8952754)
1996
43
Verrucous carcinoma of the larynx. (7816455)
1995
44
MR and MR angiography of Sturge-Weber syndrome. (8456722)
1993
45
Simultaneous purification of the neuroproteins synapsin I and synaptophysin. (1522178)
1992
46
Neuroaxonal dystrophy in childhood. Report of two second cousins with Hallerworden-Spatz disease, and a case of Seitelberger's disease. (7158329)
1982
47
A clinicopathologic study on sick sinus syndrome with histological approach to the sinoatrial node. (7401276)
1980
48
Acute obstructive uropathy due to prolapsed ectopic ureterocele. Case report. (5556873)
1971
49
Evaluation of autonomic nervous system response in patients with the dumping syndrome. (13714130)
1960
50
Local tissue reactivity (Shwartzman phenomenon) in the heart and the femoral artery of the rabbit. (20993489)
1946

Variations for Pyoderma

About this section

Expression for genes affiliated with Pyoderma

About this section
Search GEO for disease gene expression data for Pyoderma.

Pathways for genes affiliated with Pyoderma

About this section

GO Terms for genes affiliated with Pyoderma

About this section

Biological processes related to Pyoderma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1negative regulation of interleukin-6 productionGO:003271510.0IL36RN, TNF
2apoptotic signaling pathwayGO:00971909.6BTK, TNF, TNFRSF1B
3cell surface receptor signaling pathwayGO:00071669.4IFNA2, IL1R1, TNF
4inflammatory responseGO:00069549.1IFNA2, PSTPIP1, TNF, TNFRSF1B

Sources for Pyoderma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet